About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

The Bank of Israel lowered its benchmark interest rate from 3.75% to 3.50%, in line with expectations.

2026-07-06

The Bank of Israel lowered its benchmark interest rate from 3.75% to 3.50%, in line with expectations.

Other News
2026-07-06

1. The People's Bank of China (PBOC) will conduct 1 trillion yuan of outright reverse repurchase operations on July 6, with a term of 3 months. 2. Bank of China restarts 5-year large-denomination certificates of deposit. 3. The China Securities Reg

1. The People's Bank of China (PBOC) will conduct 1 trillion yuan of outright reverse repurchase operations on July 6, with a term of 3 months. 2. Bank of China restarts 5-year large-denomination certificates of deposit. 3. The China Securities Regulatory Commission (CSRC) will improve the fixed-price private placement system and strengthen regulatory requirements for convertible bonds. 4. The first half of the year's bond underwriting rankings for securities firms have been released, with the top five accounting for half of the market share. 5. BIS: Global pension funds are withdrawing from the bond market. 6. Germany plans to increase its borrowing scale in 2027 due to lower-than-expected tax revenue. 7. The yield on Japanese 10-year government bonds is approaching a 30-year high again. 8. Sumitomo Mitsui: The yield on 10-year Japanese government bonds may rise to 3% by the end of the year. 9. The Hong Kong Stock Exchange (HKEX) and China Bond Valuation Center have reached a cooperation agreement to support the launch of 5-year Chinese government bond futures on August 3. 10. Hunan Province: Encourages eligible local legal person financial institutions to issue financial bonds, rural revitalization bills, and other financing instruments.
2026-07-06

July 2-3 — The National Data Administration convened an on-site meeting in Beijing on medical data circulation within the national data-element comprehensive pilot zones to review pilot experience and push secure, compliant, and efficient use of medi

July 2-3 — The National Data Administration convened an on-site meeting in Beijing on medical data circulation within the national data-element comprehensive pilot zones to review pilot experience and push secure, compliant, and efficient use of medical data. The meeting said stronger top-level design and institutional innovation are needed. Local practice shows jurisdictions that strengthen organizational support and cross-department coordination achieved better medical data flow outcomes. Authorities were told to tighten coordination between data management and health departments, refine incentive mechanisms, and mobilize hospitals, doctors and market operators to create a positive cycle of medical data circulation and accelerated integration of Digital China and Healthy China initiatives.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.